Posted by Liju Philip | Posted in Business, India, World, biology, drugs, europe, germany, pharmaceuticals | Posted on 11-02-2008
India’s top biotechnology firm, Biocon Ltd, has agreed to buy 70 percent of German marketing firm AxiCorp GmbH for 30 million euros ($43.7 million) to boost its business in overseas markets, Biocon said on Monday.
The acquisition will enable marketing and distribution of a range of pharmaceuticals including generics, biosimilars, biologics and other products in Germany and other European countries, the Indian drugmaker said.
Full article here.
+++
Twitter
LinkedIn
Facebook
RSS
Delicious